Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in BTAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,981,741
+$386,483 QoQ
Shares Held
2,114,710
+9.2% QoQ
Ownership
6.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 47 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Derivatives in BTAI

reported options exposure · as of Jun 30, 2023
CallValue
$266,400
CallShares
2,500
PutValue
$263,736
PutShares
2,475

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. BTAI ranks #29 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,981,741 2,114,710
2026-03-31 $2,595,258 1,936,760
2025-12-31 $2,936,307 1,835,192
2025-09-30 $2,631,815 1,028,053
2024-12-31 $39,259 104,972
2024-09-30 $78,551 128,773
2024-06-30 $157,122 122,752
2024-03-31 $127,249 45,124
2023-12-31 $259,455 87,951
2023-09-30 $372,878 147,383
2023-06-30 $263,736 39,600
2023-06-30 $266,400 40,000
2023-03-31 $1,866,000 100,000
2022-06-30 $2,488,833 188,548
2022-03-31 $405,340 19,385
2021-12-31 $391,352 19,250
2021-03-31 $630,006 14,597
2020-12-31 $2,824,899 61,145
2020-09-30 $3,604,083 83,120
2020-06-30 $1,757,864 33,161